In The pharmaceutical and health industry is a strategic industry related to the national economy and the people’s livelihood，economic development and national security，and is an important foundation for building a healthy China. Globally，the sales of prescription drugs will keep rising，the market share of biotechnology drugs will continue to expand，tumor products will become the most valuable R&D projects in the market，and orphan drugs will become a new hot spot；From the domestic perspective，the pharmaceutical and health industry has broad prospects for development，the variety of innovative drugs on the market is gradually increasing，and the digital era has driven the transformation of research and development mode. Specifically，in Beijing’s pharmaceutical and health industry，the scale of the industry continues to grow，the industrial frontier advantages are prominent，the role of the industrial engine is apparent，the industrial innovation model is leading，the industrial agglomeration features are obvious，and the industrial environment is open and shared；The main problems are that R&D investment needs to be further improved，industrialization capacity needs to continue to rise，high-end manufacturing needs to continue to grow，digital transformation needs to continue to accelerate，and international competitiveness needs to be enhanced. Therefore，the next step is to focus on frontier areas and promote the leap of industrial technology level；Focus on regional cooperation and promote the coordinated development of Beijing，Tianjin and Hebei；Focus on international benchmark and strengthen new competitive advantages of enterprises；Innovate ecological construction and promote industrial development.